Cypress Capital Group Becton Dickinson & CO Transaction History

Cypress Capital Group

  • $828 Million
  • Q1 2024

A detailed history of Cypress Capital Group transactions in Becton Dickinson & CO stock. As of the latest transaction made, Cypress Capital Group holds 3,598 shares of BDX stock, worth $811,492. This represents 0.11% of its overall portfolio holdings.

Number of Shares
3,598
Previous 3,583 0.42%
Holding current value
$811,492
Previous $873,000 1.95%
% of portfolio
0.11%
Previous 0.11%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024
BUY
$233.45 - $247.73 $3,501 - $3,715
15 Added 0.42%
3,598 $890,000
Q4 2023

Jan 24, 2024
SELL
$232.24 - $267.23 $46,448 - $53,446
-200 Reduced 5.29%
3,583 $873,000
Q3 2023

Nov 02, 2023
SELL
$254.9 - $283.59 $12,999 - $14,463
-51 Reduced 1.33%
3,783 $978,000
Q2 2023

Jul 26, 2023
SELL
$238.39 - $265.32 $19,786 - $22,021
-83 Reduced 2.12%
3,834 $1.01 Million
Q1 2023

May 04, 2023
SELL
$229.71 - $259.35 $15,849 - $17,895
-69 Reduced 1.73%
3,917 $969,000
Q4 2022

Feb 14, 2023
SELL
$218.29 - $256.91 $509,925 - $600,141
-2,336 Reduced 36.95%
3,986 $1.01 Million
Q3 2022

Nov 04, 2022
SELL
$51.03 - $264.23 $32,199 - $166,729
-631 Reduced 9.08%
6,322 $1.41 Million
Q2 2022

Jul 26, 2022
BUY
$234.74 - $275.42 $474,879 - $557,174
2,023 Added 41.03%
6,953 $1.71 Million
Q1 2022

May 16, 2022
SELL
$243.64 - $270.48 $93,557 - $103,864
-384 Reduced 7.23%
4,930 $1.31 Million
Q4 2021

Feb 15, 2022
BUY
$230.08 - $250.94 $440,833 - $480,801
1,916 Added 56.39%
5,314 $1.34 Million
Q4 2020

Jan 12, 2021
SELL
$221.92 - $245.94 $3,328 - $3,689
-15 Reduced 0.44%
3,398 $850,000
Q3 2020

Oct 08, 2020
SELL
$215.77 - $276.76 $2,805 - $3,597
-13 Reduced 0.38%
3,413 $794,000
Q2 2020

Jul 10, 2020
SELL
$219.9 - $263.41 $2,638 - $3,160
-12 Reduced 0.35%
3,426 $820,000
Q3 2019

Oct 10, 2019
SELL
$230.58 - $256.08 $35,739 - $39,692
-155 Reduced 4.31%
3,438 $870,000
Q2 2019

Aug 15, 2019
SELL
$217.4 - $246.08 $85,873 - $97,201
-395 Reduced 9.9%
3,593 $905,000
Q1 2019

May 14, 2019
BUY
$206.05 - $248.17 $252,411 - $304,008
1,225 Added 44.34%
3,988 $996,000
Q4 2018

Feb 19, 2019
SELL
$204.73 - $257.93 $409 - $515
-2 Reduced 0.07%
2,763 $623,000
Q3 2018

Nov 15, 2018
SELL
$233.07 - $256.0 $104,881 - $115,200
-450 Reduced 14.0%
2,765 $722,000
Q2 2018

Aug 15, 2018
SELL
$208.1 - $233.85 $108,420 - $121,835
-521 Reduced 13.95%
3,215 $770,000
Q1 2018

May 21, 2018
SELL
$205.46 - $240.27 $32,873 - $38,443
-160 Reduced 4.11%
3,736 $809,000
Q4 2017

Feb 14, 2018
SELL
$189.0 - $222.64 $5,481 - $6,456
-29 Reduced 0.74%
3,896 $834,000
Q2 2017

Aug 15, 2017
BUY
N/A
3,925
3,925 $766,000

Others Institutions Holding BDX

# of Institutions
1,731
Shares Held
240M
Call Options Held
640K
Put Options Held
766K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.3B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Cypress Capital Group Portfolio

Follow Cypress Capital Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital Group, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email